publication venue for

• Hydroxychloroquine synergizes with anti-PD-1 immune checkpoint blockade in squamous carcinoma of the head and neck 2022
• Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network 2019
• Tolerability and efficacy of rolapitant for prevention of chemotherapy induced nausea and vomiting: a systematic review and meta-analysis of active-controlled trials 2017